FY2020 Earnings Estimate for Allscripts Healthcare Solutions, Inc. Issued By SVB Leerink (NASDAQ:MDRX)


Share on StockTwits

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) – Analysts at SVB Leerink boosted their FY2020 earnings per share estimates for shares of Allscripts Healthcare Solutions in a research note issued on Tuesday, January 12th. SVB Leerink analyst S. Davis now anticipates that the software maker will post earnings of $0.51 per share for the year, up from their prior estimate of $0.49. SVB Leerink currently has a “Market Perform” rating and a $13.00 target price on the stock. SVB Leerink also issued estimates for Allscripts Healthcare Solutions’ Q4 2020 earnings at $0.18 EPS.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Tuesday, November 3rd. The software maker reported $0.20 EPS for the quarter, beating the consensus estimate of $0.19 by $0.01. Allscripts Healthcare Solutions had a positive return on equity of 5.80% and a negative net margin of 2.77%. The firm had revenue of $402.00 million during the quarter, compared to analyst estimates of $419.75 million. During the same quarter in the prior year, the business posted $0.17 EPS. The business’s revenue for the quarter was down 9.7% compared to the same quarter last year.

Several other analysts have also commented on MDRX. Robert W. Baird lowered Allscripts Healthcare Solutions from an “outperform” rating to a “neutral” rating and set a $13.00 price objective for the company. in a report on Monday, October 19th. Cantor Fitzgerald increased their price objective on Allscripts Healthcare Solutions from $9.00 to $13.00 and gave the company a “neutral” rating in a report on Wednesday, October 14th. BidaskClub lowered Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a report on Saturday, September 19th. Bank of America raised their target price on Allscripts Healthcare Solutions from $14.00 to $16.50 and gave the stock a “buy” rating in a research note on Wednesday, November 25th. Finally, ValuEngine lowered Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research note on Monday, October 12th. Six equities research analysts have rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $10.37.

Shares of MDRX opened at $16.17 on Thursday. Allscripts Healthcare Solutions has a 12 month low of $4.56 and a 12 month high of $16.30. The stock has a fifty day moving average price of $14.45 and a 200-day moving average price of $10.42. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.85. The firm has a market cap of $2.55 billion, a PE ratio of -53.90, a P/E/G ratio of 3.17 and a beta of 1.17.

Several hedge funds have recently added to or reduced their stakes in MDRX. Nisa Investment Advisors LLC raised its position in Allscripts Healthcare Solutions by 199.6% in the third quarter. Nisa Investment Advisors LLC now owns 7,430 shares of the software maker’s stock valued at $60,000 after purchasing an additional 4,950 shares during the period. PNC Financial Services Group Inc. raised its position in Allscripts Healthcare Solutions by 147.7% in the second quarter. PNC Financial Services Group Inc. now owns 10,055 shares of the software maker’s stock valued at $68,000 after purchasing an additional 5,995 shares during the period. Venture Visionary Partners LLC purchased a new stake in Allscripts Healthcare Solutions in the third quarter valued at approximately $81,000. Aigen Investment Management LP raised its position in Allscripts Healthcare Solutions by 50.0% in the third quarter. Aigen Investment Management LP now owns 15,085 shares of the software maker’s stock valued at $123,000 after purchasing an additional 5,026 shares during the period. Finally, Bank of Montreal Can raised its position in Allscripts Healthcare Solutions by 380.8% in the second quarter. Bank of Montreal Can now owns 20,108 shares of the software maker’s stock valued at $129,000 after purchasing an additional 15,926 shares during the period. 86.05% of the stock is currently owned by hedge funds and other institutional investors.

In other news, CEO Paul Black sold 60,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Monday, December 14th. The shares were sold at an average price of $14.03, for a total transaction of $841,800.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Lisa Khorey sold 15,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Wednesday, November 18th. The shares were sold at an average price of $12.75, for a total transaction of $191,250.00. Following the sale, the insider now directly owns 251,626 shares in the company, valued at approximately $3,208,231.50. The disclosure for this sale can be found here. 1.42% of the stock is currently owned by insiders.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Read More: Overbought

Earnings History and Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.